82 FR 58557 - Schedules of Controlled Substances: Placement of MT-45 Into Schedule I
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 238 (December 13, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 238 (December 13, 2017)
| Page Range | 58557-58559 | |
| FR Document | 2017-26853 |
[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)] [Rules and Regulations] [Pages 58557-58559] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-26853] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration 21 CFR Part 1308 [Docket No. DEA-451] Schedules of Controlled Substances: Placement of MT-45 Into Schedule I AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Final order. ----------------------------------------------------------------------- SUMMARY: With the issuance of this final order, the Administrator of the Drug Enforcement Administration places the substance MT-45 (Systematic IUPAC Name: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), including its salts, isomers, and salts of isomers into schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act and is required in order for the United States to discharge its obligations under the Single Convention on Narcotic Drugs, 1961. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, MT-45. DATES: Effective January 12, 2018. FOR FURTHER INFORMATION CONTACT: Michael J. Lewis, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598- 6812. SUPPLEMENTARY INFORMATION: Legal Authority Section 201(d)(1) of the Controlled Substances Act (CSA) (21 U.S.C. 811(d)(1)) states that, if control of a substance is required ``by United States obligations under international treaties, conventions, or protocols in effect on October 27, 1970, the Attorney General shall issue an order controlling such drug under the schedule he deems most appropriate to carry out such obligations, without regard to the findings required by subsection (a) of this section [811(a)] or section 812(b) . . . and without regard to the procedures prescribed by subsections (a) and (b) of this section [21 U.S.C. 811(a) and (b)] . . . .'' If a substance is added to one of the schedules of the Single Convention on Narcotic Drugs, 1961 (``Single Convention''), then, in accordance with article 3, paragraph 7 of the Convention, as a signatory Member State, the United States is obligated to control the substance under its national drug control legislation, the CSA. The Attorney General has delegated scheduling authority under 21 U.S.C. 811 to the Administrator of the DEA. 28 CFR 0.100. Background On May 17, 2016, the Secretary-General of the United Nations advised the Secretary of State of the United States, by letter, that during the 59th session of the Commission on Narcotic Drugs, MT-45 was added to schedule I of the Single Convention. This letter was prompted by a decision at the 59th session of the Commission on Narcotic Drugs in March 2016 to schedule MT-45 under schedule I of the Single Convention. As a signatory Member State to the Single Convention, the United States is obligated to control MT-45 under its national drug control legislation, the CSA, in the schedule deemed most appropriate to carry out its international obligations. 21 U.S.C. 811(d)(1). MT-45 MT-45 is an opioid analgesic drug with pharmacological effects similar to morphine. MT-45 was demonstrated to produce physical dependence in mice. This compound is a piperazine derivative and is structurally unrelated to most other opioids. There are two enantiomers of MT-45 (R and S). Both enantiomers bind to opioid receptors, however (S)-(+)-MT-45 binds with a greater affinity than that of (R)-(-)-MT-45. In functional studies, (S)-(+)-MT-45 has an analgesic effect similar to morphine. In comparison, the analgesic effect of (R)-(-)-MT-45 is low. Starting in 2013, MT-45 began appearing on the internet for sale as a `legal' opioid. Recent reports from Japan have indicated that MT-45 is present in herbal and chemical mixtures containing synthetic cannabinoids and/or synthetic cathinones. Deaths associated with MT-45 abuse have occurred in the United States and in Europe. In addition, there have been at least 13 non-fatal overdoses associated with abuse of MT-45. There are no published studies as to the safety of MT-45 for human use. The DEA is not aware of any claims or any medical or scientific literature suggesting that MT-45 has a currently accepted medical use in treatment in the United States. Accordingly, the DEA has not requested that the Department of Health and Human Services (HHS) conduct a scientific and medical evaluation of the substance's medical utility. Furthermore, the DEA is not required under 21 U.S.C. 811(d)(1) to make any findings required by 21 U.S.C. 811(a) or 812(b), and is not required to follow the procedures prescribed by 21 U.S.C. 811(a) and (b). Therefore, consistent with the framework of 21 U.S.C. 811(d), the DEA concludes that MT-45 has no currently accepted medical use in treatment in the United States and is most appropriately placed in schedule I of the CSA. Conclusion In order to meet the obligations of the United States under the Single Convention on Narcotic Drugs, 1961, and because MT-45 has no currently accepted medical use in treatment in the United States, the Administrator of the Drug Enforcement Administration has determined that this substance should be placed in schedule I of the Controlled Substances Act. Requirements for Handling Upon the effective date of this final order, MT-45 will become subject to the regulatory controls and administrative, civil, and criminal sanctions applicable to the manufacture, distribution, importation, exportation, engagement in research, and conduct of instructional [[Page 58558]] activities, and possession of schedule I controlled substances including the following: 1. Registration. Any person who handles (manufactures, distributes, imports, exports, engages in research or conducts instructional activities with, or possesses), or who desires to handle, MT-45 must be registered with the DEA to conduct such activities pursuant to 21 U.S.C. 822, 823, 957, and 958 and in accordance with 21 CFR parts 1301 and 1312, as of January 12, 2018. Any person who currently handles MT- 45, and is not registered with the DEA, must submit an application for registration and may not continue to handle MT-45 as of January 12, 2018, unless the DEA has approved that application for registration pursuant to 21 U.S.C. 822, 823, 957, 958, and in accordance with 21 CFR parts 1301 and 1312. 2. Disposal of stocks. Any person who does not desire or is not able to obtain a schedule I registration to handle MT-45 must surrender all quantities of currently held MT-45, or may transfer all quantities of currently held MT-45 to a person registered with the DEA on or before January 12, 2018 in accordance with all applicable federal, state, local, and tribal laws. As of January 12, 2018, MT-45 must be disposed of in accordance with 21 CFR part 1317, in addition to all other applicable federal, state, local, and tribal laws. 3. Security. MT-45 will be subject to schedule I security requirements and must be handled and stored pursuant to 21 U.S.C. 821, 823, 871(b), and in accordance with 21 CFR 1301.71-1301.93, as of January 12, 2018. 4. Labeling and packaging. As of January 12, 2018, all labels, labeling, and packaging for commercial containers of MT-45 must be in compliance with 21 U.S.C. 825, 958(e), and be in accordance with 21 CFR part 1302. 5. Inventory. Every DEA registrant who possesses any quantity of MT-45 on the effective date of this order must take an inventory of all stocks of this substance on hand, pursuant to 21 U.S.C. 827 and 958, and in accordance with 21 CFR 1304.03, 1304.04, and 1304.11. After the initial inventory, every DEA registrant must take an inventory of all MT-45 on hand on a biennial basis, pursuant to 21 U.S.C. 827 and 958, and in accordance with 21 CFR 1304.03, 1304.04, and 1304.11. 6. Records. All DEA registrants must maintain records with respect to MT-45 pursuant to 21 U.S.C. 827 and 958, and in accordance with 21 CFR parts 1304, and 1312, and 1317 as of January 12, 2018. 7. Reports. All DEA registrants who manufacture or distribute MT-45 must submit reports pursuant to 21 U.S.C. 827 and in accordance with 21 CFR parts 1304 and 1312 as of January 12, 2018. 8. Order Forms. All DEA registrants who distribute MT-45 must comply with order form requirements pursuant to 21 U.S.C. 828 and in accordance with 21 CFR part 1305 as of January 12, 2018. 9. Importation and Exportation. All importation and exportation of MT-45 must be in compliance with 21 U.S.C. 952, 953, 957, 958, and in accordance with 21 CFR part 1312 as of January 12, 2018. 10. Quota. Only DEA registered manufacturers may manufacture MT-45 in accordance with a quota assigned pursuant to 21 U.S.C. 826 and in accordance with 21 CFR part 1303 as of January 12, 2018. 11. Liability. Any activity involving MT-45 not authorized by, or in violation of the CSA, occurring as of January 12, 2018, is unlawful, and may subject the person to administrative, civil, and/or criminal sanctions. Regulatory Analyses Executive Order 12866, Regulatory Planning and Review This action is not a significant regulatory action as defined by Executive Order 12866 (Regulatory Planning and Review), section 3(f), and, accordingly, this action has not been reviewed by the Office of Management and Budget (OMB). Executive Order 13132, Federalism This action does not have federalism implications warranting the application of Executive Order 13132. The action does not have substantial direct effects on the States, on the relationship between the national government and the States, or the distribution of power and responsibilities among the various levels of government. Executive Order 13175 This action does not have tribal implications warranting the application of Executive Order 13175. The action does not have substantial direct effects on one or more Indian tribes, on the relationship between the Federal government and Indian tribes, or on the distribution of power and responsibilities between the Federal government and Indian tribes. Administrative Procedure Act The CSA provides for an expedited scheduling action where control is required by the United States obligations under international treaties, conventions, or protocols. 21 U.S.C. 811(d)(1). If control is required pursuant to such international treaty, convention, or protocol, the Attorney General must issue an order controlling such drug under the schedule he deems most appropriate to carry out such obligations, without regard to the findings or procedures otherwise required for scheduling actions. To the extent that 21 U.S.C. 811(d)(1) directs that if control is required by the United States obligations under international treaties, conventions, or protocols in effect on October 27, 1970, scheduling actions shall be issued by order (as compared to scheduling pursuant to 21 U.S.C. 811(a) by rule), the DEA believes that the notice and comment requirements of section 553 of the Administrative Procedure Act (APA), 5 U.S.C. 553, do not apply to this scheduling action. In the alternative, even if this action does constitute ``rule making'' under 5 U.S.C. 551(5), this action is exempt from the notice and comment requirements of 5 U.S.C. 553 pursuant to 21 U.S.C. 553(a)(1) as an action involving a foreign affairs function of the United States given that this action is being done in accordance with 21 U.S.C. 811(d)(1)'s requirement that such action be taken to comply with the United States obligations under the specified international agreement. Regulatory Flexibility Act The Regulatory Flexibility Act (RFA) (5 U.S.C. 601-612) applies to rules that are subject to notice and comment under section 553(b) of the APA or any other law. As explained above, the CSA exempts this final order from notice and comment. Consequently, the RFA does not apply to this action. Paperwork Reduction Act of 1995 This action does not impose a new collection of information under the Paperwork Reduction Act of 1995. 44 U.S.C. 3501-3521. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Congressional Review Act This action is not a major rule as defined by section 804 of the Small Business Regulatory Enforcement Fairness Act of 1996 (Congressional Review Act (CRA)). This order will not result in: ``an annual effect on the economy of $100,000,000 or more; a major increase in costs or prices for consumers, individual industries, Federal, State, or local government agencies, or geographic regions; or significant adverse effects on [[Page 58559]] competition, employment, investment, productivity, innovation, or on the ability of United States-based enterprises to compete with foreign based enterprises in domestic and export markets.'' However, pursuant to the CRA, the DEA has submitted a copy of this order to both Houses of Congress and to the Comptroller General. List of Subjects in 21 CFR Part 1308 Administrative practice and procedure, Drug traffic control, Reporting and recordkeeping requirements. For the reasons set out above, 21 CFR part 1308 is amended as follows: PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES 0 1. The authority citation for part 1308 continues to read as follows: Authority: 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise noted. 0 2. Amend Sec. 1308.11 by: 0 a. Redesignating paragraphs (b)(40) through (57) as (b)(41) through (58); 0 b. Adding new paragraph (b)(40). The addition reads as follows: Sec. 1308.11 Schedule I. * * * * * (b) * * * (40) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) . . . (9560) * * * * * Dated: December 5, 2017. Robert W. Patterson, Acting Administrator. [FR Doc. 2017-26853 Filed 12-12-17; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Rules and Regulations 58557
treated as often as necessary to prevent distribute, import, export, engage in produce physical dependence in mice.
growth of fungi. Do not use formalin research or conduct instructional This compound is a piperazine
which has been subjected to activities with, or possess), or propose derivative and is structurally unrelated
temperatures below 40 °F, or allowed to to handle, MT–45. to most other opioids. There are two
freeze. Treatments in tanks and DATES: Effective January 12, 2018. enantiomers of MT–45 (R and S). Both
raceways should never exceed 1 hour FOR FURTHER INFORMATION CONTACT: enantiomers bind to opioid receptors,
for fish or 4 hours for penaeid shrimp Michael J. Lewis, Diversion Control however (S)-(+)-MT–45 binds with a
(even if they show no sign of distress), Division, Drug Enforcement greater affinity than that of (R)-(¥)-MT–
nor should it exceed 15 minutes for fish Administration; Mailing Address: 8701 45. In functional studies, (S)-(+)-MT–45
eggs. Do not apply formalin to ponds Morrissette Drive, Springfield, Virginia has an analgesic effect similar to
with water warmer than 27 °C (80 °F), 22152; Telephone: (202) 598–6812. morphine. In comparison, the analgesic
when a heavy bloom of phytoplankton SUPPLEMENTARY INFORMATION: effect of (R)-(¥)-MT–45 is low.
is present, or when the concentration of Starting in 2013, MT–45 began
dissolved oxygen is less than 5 Legal Authority
appearing on the internet for sale as a
milligrams per liter. Section 201(d)(1) of the Controlled ‘legal’ opioid. Recent reports from Japan
Substances Act (CSA) (21 U.S.C. have indicated that MT–45 is present in
PART 558—NEW ANIMAL DRUGS FOR 811(d)(1)) states that, if control of a
USE IN ANIMAL FEEDS herbal and chemical mixtures
substance is required ‘‘by United States containing synthetic cannabinoids and/
■ 13. The authority citation for part 558 obligations under international treaties, or synthetic cathinones. Deaths
continues to read as follows: conventions, or protocols in effect on associated with MT–45 abuse have
October 27, 1970, the Attorney General occurred in the United States and in
Authority: 21 U.S.C. 354, 360b, 360ccc,
360ccc–1, 371. shall issue an order controlling such Europe. In addition, there have been at
drug under the schedule he deems most least 13 non-fatal overdoses associated
§ 558.58 [Amended] appropriate to carry out such with abuse of MT–45. There are no
■ 14. In § 558.58, remove paragraphs obligations, without regard to the published studies as to the safety of
(f)(4) and (5). findings required by subsection (a) of MT–45 for human use. The DEA is not
this section [811(a)] or section 812(b) aware of any claims or any medical or
§ 558.366 [Amended] . . . and without regard to the scientific literature suggesting that
■ 15. In § 558.366, remove paragraph procedures prescribed by subsections (a) MT–45 has a currently accepted medical
(e). and (b) of this section [21 U.S.C. 811(a) use in treatment in the United States.
Dated: December 5, 2017. and (b)] . . . .’’ If a substance is added Accordingly, the DEA has not requested
Leslie Kux,
to one of the schedules of the Single that the Department of Health and
Convention on Narcotic Drugs, 1961 Human Services (HHS) conduct a
Associate Commissioner for Policy.
(‘‘Single Convention’’), then, in scientific and medical evaluation of the
[FR Doc. 2017–26753 Filed 12–12–17; 8:45 am] accordance with article 3, paragraph 7 substance’s medical utility.
BILLING CODE 4164–01–P of the Convention, as a signatory Furthermore, the DEA is not required
Member State, the United States is under 21 U.S.C. 811(d)(1) to make any
obligated to control the substance under findings required by 21 U.S.C. 811(a) or
DEPARTMENT OF JUSTICE its national drug control legislation, the 812(b), and is not required to follow the
CSA. The Attorney General has procedures prescribed by 21 U.S.C.
Drug Enforcement Administration
delegated scheduling authority under 21 811(a) and (b). Therefore, consistent
U.S.C. 811 to the Administrator of the with the framework of 21 U.S.C. 811(d),
21 CFR Part 1308
DEA. 28 CFR 0.100. the DEA concludes that MT–45 has no
[Docket No. DEA–451] currently accepted medical use in
Background
Schedules of Controlled Substances: treatment in the United States and is
On May 17, 2016, the Secretary- most appropriately placed in schedule I
Placement of MT–45 Into Schedule I General of the United Nations advised of the CSA.
AGENCY: Drug Enforcement the Secretary of State of the United
Administration, Department of Justice. States, by letter, that during the 59th Conclusion
ACTION: Final order. session of the Commission on Narcotic
Drugs, MT–45 was added to schedule I In order to meet the obligations of the
SUMMARY: With the issuance of this final of the Single Convention. This letter United States under the Single
order, the Administrator of the Drug was prompted by a decision at the 59th Convention on Narcotic Drugs, 1961,
Enforcement Administration places the session of the Commission on Narcotic and because MT–45 has no currently
substance MT–45 (Systematic IUPAC Drugs in March 2016 to schedule accepted medical use in treatment in the
Name: 1-cyclohexyl-4-(1,2- MT–45 under schedule I of the Single United States, the Administrator of the
diphenylethyl)piperazine), including its Convention. As a signatory Member Drug Enforcement Administration has
salts, isomers, and salts of isomers into State to the Single Convention, the determined that this substance should
schedule I of the Controlled Substances United States is obligated to control be placed in schedule I of the Controlled
Act. This scheduling action is pursuant MT–45 under its national drug control Substances Act.
to the Controlled Substances Act and is legislation, the CSA, in the schedule Requirements for Handling
required in order for the United States deemed most appropriate to carry out its
sradovich on DSK3GMQ082PROD with RULES
to discharge its obligations under the international obligations. 21 U.S.C. Upon the effective date of this final
Single Convention on Narcotic Drugs, 811(d)(1). order, MT–45 will become subject to the
1961. This action imposes the regulatory regulatory controls and administrative,
controls and administrative, civil, and MT–45 civil, and criminal sanctions applicable
criminal sanctions applicable to MT–45 is an opioid analgesic drug to the manufacture, distribution,
schedule I controlled substances on with pharmacological effects similar to importation, exportation, engagement in
persons who handle (manufacture, morphine. MT–45 was demonstrated to research, and conduct of instructional
VerDate Sep<11>2014 16:39 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00025 Fmt 4700 Sfmt 4700 E:\FR\FM\13DER1.SGM 13DER1](https://thefederalregister.org/doc/82_FR_58795/page/1.svg)
![Federal Register / Vol. 82, No. 238 / Wednesday, December 13, 2017 / Rules and Regulations 58559
competition, employment, investment, 1977 (SMCRA or the Act). Oklahoma II. Submission of the Amendment
productivity, innovation, or on the proposed revisions to its regulations By letter dated September 25, 2015
ability of United States-based regarding: Permit eligibility for permits (Administrative Record No. OK–1003),
enterprises to compete with foreign with violations on lands eligible for Oklahoma sent us an amendment to its
based enterprises in domestic and remining; permit suspension or program under SMCRA (30 U.S.C. 1201
export markets.’’ However, pursuant to rescission posting locations and appeal et seq.). Oklahoma submitted the
the CRA, the DEA has submitted a copy procedures; requiring GPS coordinates proposed amendment on its own
of this order to both Houses of Congress for aspects of permit maps; topsoil initiative.
and to the Comptroller General. removal distances; blasting records We announced receipt of the
List of Subjects in 21 CFR Part 1308 requirements; annual reporting proposed amendment in the February 8,
requirements; temporary cessation of 2016, Federal Register (81 FR 6477). In
Administrative practice and operations requirements; casing and the same document, we opened the
procedure, Drug traffic control, sealing temporary underground public comment period and provided an
Reporting and recordkeeping openings; right of entry requirements; opportunity for a public hearing or
requirements. surface drainage associated with auger meeting on the adequacy of the
For the reasons set out above, 21 CFR mining; correcting reference errors; amendment. We did not hold a public
part 1308 is amended as follows: updating addresses; and correcting hearing or meeting because no one
spelling and grammatical errors. requested one. The public comment
PART 1308—SCHEDULES OF Oklahoma intended to revise its period ended on March 9, 2016. We did
CONTROLLED SUBSTANCES program to be no less effective than the not receive any comments.
Federal regulations and to improve
■ 1. The authority citation for part 1308 III. OSMRE’s Findings
operational efficiency.
continues to read as follows: We are approving the amendment as
Authority: 21 U.S.C. 811, 812, 871(b), DATES: The effective date is January 12, described below. The following are the
956(b), unless otherwise noted. 2018. findings we made concerning
■ 2. Amend § 1308.11 by: FOR FURTHER INFORMATION CONTACT: Bill Oklahoma’s amendment under SMCRA
■ a. Redesignating paragraphs (b)(40) Joseph, Director, Tulsa Field Office, and the Federal regulations at 30 CFR
through (57) as (b)(41) through (58); Office of Surface Mining Reclamation 732.15 and 732.17. Any revisions that
■ b. Adding new paragraph (b)(40). and Enforcement, 1645 South 101st East we do not specifically discuss below
The addition reads as follows: Avenue, Suite 145, Tulsa, Oklahoma concerning non-substantive wording or
74128–4629. Telephone: 918–581–6431 editorial changes can be found in the
§ 1308.11 Schedule I. ext. 230. Email: bjoseph@osmre.gov. full text of the program amendment
* * * * * available at www.regulations.gov.
(b) * * * SUPPLEMENTARY INFORMATION:
1. Subchapter 15. Requirements for
(40) MT–45 (1-cyclohexyl-4-(1,2- I. Background on the Oklahoma Program Permits and Permit Processing
diphenylethyl)piperazine) . . . (9560) II. Submission of the Amendment
III. OSMRE’s Findings
Oklahoma removed paragraphs
* * * * * 460:20–15–6.7(a)(2)(A) and (B)
IV. Summary and Disposition of Comments
Dated: December 5, 2017. regarding permit eligibility and
V. OSMRE’s Decision
Robert W. Patterson, VI. Procedural Determinations unabated violations at remining sites
Acting Administrator. issued before September 30, 2004, and
[FR Doc. 2017–26853 Filed 12–12–17; 8:45 am] I. Background on the Oklahoma added language to paragraph (a)(2) to
BILLING CODE 4410–09–P
Program substantively match the Federal
requirements of 30 CFR 773.13(a)(2).
Section 503(a) of the Act permits a Oklahoma modified section 460:20–
State to assume primacy for the 15–10.1(c) regarding the suspension and
DEPARTMENT OF THE INTERIOR regulation of surface coal mining and rescission appeal process so that it
reclamation operations on non-Federal substantively matches the counterpart
Office of Surface Mining Reclamation and non-Indian lands within its borders
and Enforcement Federal regulations at 30 CFR 773.23(c).
by demonstrating that its program Additionally, Oklahoma modified
includes, among other things, State laws 460:20–15–10.1(d) and added paragraph
30 CFR Part 936 and regulations that govern surface coal (e) to substantively match the
[SATS No. OK–037–FOR; Docket ID: OSM– mining and reclamation operations in requirements of 30 CFR 773.23 (d).
2015–0006; S1D1S SS08011000 SX064A000 accordance with the Act and consistent We find that Oklahoma’s changes to
189S180110; S2D2S SS08011000 with the Federal regulations. See 30 this subchapter substantively match the
SX064A000 18XS501520] U.S.C. 1253(a)(1) and (7). On the basis counterpart Federal requirements and
of these criteria, the Secretary of the do not make its rules or regulations less
Oklahoma Regulatory Program
Interior conditionally approved the effective than the Federal requirements.
AGENCY: Office of Surface Mining Oklahoma program on January 19, 1981. Therefore, we are approving Oklahoma’s
Reclamation and Enforcement, Interior. You can find background information revisions.
ACTION: Final rule; approval of on the Oklahoma program, including
the Secretary’s findings, the disposition 2. Subchapter 29. Underground Mining
amendment.
sradovich on DSK3GMQ082PROD with RULES
of comments, and the conditions of Permit Applications: Minimum
SUMMARY: We, the Office of Surface approval of the Oklahoma program in Requirements for Information on
Mining Reclamation and Enforcement the January 19, 1981, Federal Register Environmental Resources
(OSMRE), are approving an amendment (46 FR 4902). You can also find later Oklahoma added the requirement for
to the Oklahoma regulatory program actions concerning the Oklahoma GPS coordinates for each building on
(Oklahoma program) under the Surface program and program amendments at 30 permit application maps in section
Mining Control and Reclamation Act of CFR 936.10, 936.15, and 936.16. 460:20–29–10(4). Although there is no
VerDate Sep<11>2014 15:49 Dec 12, 2017 Jkt 244001 PO 00000 Frm 00027 Fmt 4700 Sfmt 4700 E:\FR\FM\13DER1.SGM 13DER1](https://thefederalregister.org/doc/82_FR_58795/page/3.svg)
Document Created: 2017-12-13 01:23:55
Document Modified: 2017-12-13 01:23:55
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Rules and Regulations | |
| Action | Final order. | |
| Dates | Effective January 12, 2018. | |
| Contact | Michael J. Lewis, Diversion Control | |
| FR Citation | 82 FR 58557 | |
| CFR Associated | Administrative Practice and Procedure; Drug Traffic Control and Reporting and Recordkeeping Requirements |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR